Labeler
Novartis Pharmaceuticals Corporation NDC Codes
Novartis Pharmaceuticals Corporation lists 165 finished drug products in the FDA NDC Directory under NDC labeler code 0078.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Entresto, Promacta, Jadenu, Exforge HCT, Vijoice, Cosentyx, Afinitor, Zortress, Tafinlar, Mekinist, Scemblix, Piqray, Mayzent, Kisqali, Sandostatin LAR Depot
- Active ingredients
- Valsartan, Everolimus, Sacubitril, Eltrombopag olamine, Deferasirox, Amlodipine besylate, Alpelisib, Hydrochlorothiazide, Secukinumab, Dabrafenib mesylate, Trametinib dimethyl sulfoxide, Asciminib hydrochloride
- NDC labeler codes
- 0078
- Strengths (from the 100 most recently listed products)
- Valsartan 160 mg/1; Amlodipine besylate 10 mg/1; Ribociclib succinate 200 mg/1; Hydrochlorothiazide 25 mg/1; Alpelisib 50 mg/1; Eltrombopag olamine 25 mg/1; Eltrombopag olamine 12.5 mg/1; Deferasirox 180 mg/1; Deferasirox 360 mg/1; Deferasirox 90 mg/1; Sacubitril 49 mg/1; Valsartan 51 mg/1; Sacubitril 24 mg/1; Valsartan 26 mg/1; Imatinib mesylate 400 mg/1; Everolimus 5 mg/1; Amlodipine besylate 5 mg/1; Hydrochlorothiazide 12.5 mg/1; Remibrutinib 25 mg/1; Atrasentan hydrochloride .75 mg/1
- Dosage forms
- Tablet, Film coated, Tablet, Capsule, Kit, Injection, Solution, Injection, Granule, Tablet, For suspension, Injection, Suspension, Patch, Extended release, Pellet, Injection, Powder, Lyophilized, For solution, Powder, For suspension, Injection, Solution, Concentrate, Powder, For solution, Capsule, Liquid filled, Solution/ drops, Suspension/ drops
- Routes
- Oral, Intravenous, Subcutaneous, Ophthalmic, Transdermal, Intravitreal
- Drug classes (FDA established)
- Kinase Inhibitor, Angiotensin 2 Receptor Blocker, mTOR Inhibitor Immunosuppressant, Neprilysin Inhibitor, Thrombopoietin Receptor Agonist, Iron Chelator, Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker, Sphingosine 1-phosphate Receptor Modulator, Thiazide Diuretic, Interleukin-17A Antagonist, Cholinesterase Inhibitor, CD19-directed Chimeric Antigen Receptor, Genetically-modified Autologous T Cells, Antimalarial, Endothelin Receptor Antagonist, Corticosteroid, Complement Factor B Inhibitor, Radioligand Therapeutic Agent, Selectin Blocker, Anthelmintic, Topoisomerase Inhibitor, Nucleoside Metabolic Inhibitor, Lymphocyte Function-Associated Antigen-1 Antagonist, Nonsteroidal Anti-inflammatory Drug, CD20-directed Cytolytic Antibody
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 136 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Lotrelamlodipine besylate and benazepril hydrochloride | Amlodipine besylate 10 mg/1; Benazepril hydrochloride 20 mg/1 | CapsuleOral | 0078-0364 | — | — |
| Lotrelamlodipine besylate and benazepril hydrochloride | Amlodipine besylate 5 mg/1; Benazepril hydrochloride 10 mg/1 | CapsuleOral | 0078-0405 | 00078-0405-05 | — |
| Sandimmunecyclosporine | Cyclosporine 25 mg/1 | Capsule, Liquid filledOral | 0078-0240 | 00078-0240-15 | — |
| Sandimmunecyclosporine | Cyclosporine 100 mg/1 | Capsule, Liquid filledOral | 0078-0241 | 00078-0241-15 | — |
| Sandostatinoctreotide acetate | Octreotide acetate 100 ug/mL | Injection, SolutionIntravenous, Subcutaneous | 0078-0181 | 00078-0181-01 | — |
| Sandostatinoctreotide acetate | Octreotide acetate 500 ug/mL | Injection, SolutionIntravenous, Subcutaneous | 0078-0182 | 00078-0182-01 | — |
| Sandostatinoctreotide acetate | Octreotide acetate 50 ug/mL | Injection, SolutionIntravenous, Subcutaneous | 0078-0180 | 00078-0180-01 | — |
| TobraDextobramycin and dexamethasone | Tobramycin 3 mg/g; Dexamethasone 1 mg/g | OintmentOphthalmic | 0078-0876 | 00078-0876-01 | — |
| Tegretolcarbamazepine | Carbamazepine 100 mg/5mL | SuspensionOral | 0078-0508 | 00078-0508-83 | — |
| Lampreneclofazimine | Clofazimine 50 mg/1 | Capsule, Liquid filledOral | 0078-1049 | 00078-1049-05 | — |
| Sandimmunecyclosporine | Cyclosporine 50 mg/mL | InjectionIntravenous | 0078-0109 | 00078-0109-01 | — |
| Tobrextobramycin | Tobramycin 3 mg/g | OintmentOphthalmic | 0078-0813 | 00078-0813-01 | — |
| Maxitrolneomycin sulfate, polymyxin b sulfate and dexamethasone | Neomycin sulfate 3.5 mg/g + 2 more ingredients | OintmentOphthalmic | 0078-0771 | 00078-0771-01 | — |
| Desferaldeferoxamine mesylate | Deferoxamine mesylate 500 mg/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous, Subcutaneous | 0078-0467 | 00078-0467-91 | — |
| Tegretolcarbamazepine | Carbamazepine 200 mg/1 | TabletOral | 0078-0509 | 00078-0509-0500078-0509-20 | — |
Novartis Pharmaceuticals Corporation: common questions
- What is Novartis Pharmaceuticals Corporation's NDC labeler code?
- 0078. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Novartis Pharmaceuticals Corporation?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.